Carcinoma

Sarcoma

Lymphoma

Target lesions

Baseline

69

2

3

1^st assessment

56

1

3

2^nd assessment

50

0

3

Non target lesions

Baseline

35

0

1

1^st assessment

26

0

1

2^nd assessment

21

0

0

New lesions

1^st assessment

11

0

0

2^nd assessment

28

1

0